Medical News Summary: COX-2 inhibitors and heart attack risk
About: COX-2 inhibitors and heart attack risk
Date: 15 December 2004
Source: Science Daily
Medical News Summary (summary of medical news story as reported by Science Daily): Researchers from the University of Pennsylvania School of Medicine have found that Vioxx poses a greater heart attack risk than Celebrex but neither of them showed a significant increase in risk of heart attack when compared to people not using the drugs. They found that NSAIDs (nonsteroidal anti-inflammatory drugs such as aspirin, ibuprofen and naxproxen) posed a lower heart attack risk than COX-2 inhibitors. Vioxx’s higher risk was probably due to factors such as blood pressure, endothelial function and oxidative stress. Researchers suggest that results indicating that Celebrex reduced heart attack risk compared to NSAIDs are not necessarily conclusive. Further detailed trials are needed to confirm all of the above results.
URL: http://www.sciencedaily.com/releases/2004/12/041206205711.htm
Related Disease Topics: Heart attack, Pain, High blood pressure, Oxidative stress
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Research
- research and heart attack
- research and pain
- research and high blood pressure
- Research and oxidative stress
- Medication
- medication and heart attack
- medication and pain
- medication and high blood pressure
- Medication and oxidative stress
- Medication and COX-2 inhibitors
- Medication and aspirin
- Medication and ibuprofen
- Medication and naxproxen
- Medication and Celebrex
- Medication and Vioxx
- cause of heart attack
- death from heart attack
Medical Tools & Articles:
Next articles:
Medical Articles: